Cargando…
CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance
Metastasis is the primary cause of cancer patient morbidity and mortality, but due to persisting gaps in our knowledge, it remains untreatable. Metastases often occur as patient tumors progress or recur after initial therapy. Tumor recurrence at the primary site may be driven by a cancer stem-like c...
Autores principales: | Foster, Brittni M., Zaidi, Danish, Young, Tyler R., Mobley, Mary E., Kerr, Bethany A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874688/ https://www.ncbi.nlm.nih.gov/pubmed/29518044 http://dx.doi.org/10.3390/biomedicines6010031 |
Ejemplares similares
-
CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance
por: Harris, Koran S., et al.
Publicado: (2021) -
Evaluation of the Expression of C-kit (CD117) in Ependymomas and Oligodendrogliomas
por: Zavalhia, Lisiane Silveira, et al.
Publicado: (2012) -
Erratum to “Evaluation of the Expression of C-Kit (CD117) in Ependymomas and Oligodendrogliomas”
por: Zavalhia, Lisiane Silveira, et al.
Publicado: (2014) -
KIT (CD117) Expression in Benign and Malignant Sweat Gland Tumors
por: Nishida, Haruto, et al.
Publicado: (2015) -
Evaluation of c-kit protein (CD117) expression in common salivary gland neoplasms
por: Salehinejad, Jahanshah, et al.
Publicado: (2014)